The market for VR1’s tech is too infant. Industries have been slow adopting it. And trials don’t appear to be leading to broader adoption within an organisation or industry, yet.
Can VR1 survive? They have government and industry support. And they are ASX listed. So capital to keep going shouldn’t be a concern as long as progress is being made imv.
I hope the strategy of creating verticals is the right one. It wouldn’t be if you couldn’t be assured that access to capital would be available. I assume uptake will be swift when it comes so having a broad suite of solutions and attracting the right people at this time is critical to becoming a future big player in the the space imv.
I’d like them to strengthen their board ASAP. I’d like to see some independent directors and chair.
- Forums
- ASX - By Stock
- VR1
- Ann: Toshiba Tec to Distribute Vection's XR Portfolio
Ann: Toshiba Tec to Distribute Vection's XR Portfolio, page-48
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $38.47M |
Open | High | Low | Value | Volume |
3.0¢ | 3.2¢ | 2.9¢ | $437.2K | 14.25M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1430263 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 640246 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1430263 | 0.029 |
4 | 484856 | 0.028 |
3 | 228555 | 0.027 |
1 | 769230 | 0.026 |
6 | 2930000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 581465 | 4 |
0.033 | 946232 | 11 |
0.034 | 1971173 | 6 |
0.035 | 3045077 | 9 |
0.036 | 616130 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online